Pharmacoinvasive Therapy in Acute Myocardial Infarction

Tracking the origins, evolution, and limitations of the current treatment methods of pharmacoinvasive acute myocardial infarction, this handbook highlights new clinical trial data - showcasing the potential of the combined treatment approach and controversial issues surrounding this emerging therapeutic modality.

Summarizing the progressive nature of developments in pharmacoinvasive therapy, "Pharmacoinvasive Acute Myocardial Infarction": * stresses the importance of pharmacoinvasive therapy for enhanced cardiac survival * considers the efficacy and limitations of the two components of pharmacoinvasive therapy: percutaneous coronary intervention and the treatment of ST segment elevation myocardial infarction * discusses the significance of evidence-based data to improve treatment outcomes for patients with acute myocardial infarction * emphasizes the need for the design and execution of studies to delineate optimal treatment regimens for specific patient populations with STEMI * covers early attempts to combine thrombolysis and primary angioplasty. An important presentation and exploration of advances in the field, this book will prove to be invaluable for all cardiologists and clinical pharmacologists.